Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CRL
CRL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CRL News
Charles River Laboratories to Release Q1 2026 Financial Results
4d ago
Newsfilter
RBC Capital Markets Initiates Outperform Rating on CRL Amid NAMs Disruption
6d ago
seekingalpha
Latest Rating Changes on Wall Street
6d ago
CNBC
Charles River Laboratories Partners with American Heart Association for Cardiovascular Health
Apr 09 2026
Newsfilter
Booking Holdings Plummets 96.8% Year-to-Date
Apr 06 2026
NASDAQ.COM
NYSE Issues Daily Pre-Market Advisory
Apr 06 2026
PRnewswire
CNBC Launches Advocacy Platform for Rare Diseases
Mar 20 2026
CNBC
FDA Issues Draft Guidance on Alternatives to Animal Testing
Mar 18 2026
seekingalpha
Analysis and Outlook: Economic Consequences
Mar 12 2026
Barron's
Top and Bottom Performing S&P 500 Stocks in February
Feb 27 2026
Barron's
Charles River Laboratories Plans Business Divestitures
Feb 25 2026
Benzinga
Mizuho Lowers Target Price for Charles River Laboratories International Inc. to $175 from $215
Feb 20 2026
moomoo
Charles River Laboratories Q4 2025 Earnings Highlights
Feb 18 2026
seekingalpha
US Stock Markets Rise on Strong Economic Data
Feb 18 2026
NASDAQ.COM
Stock Movements of Various Companies Analyzed
Feb 18 2026
CNBC
US Stock Markets Rise on Positive Economic Data
Feb 18 2026
NASDAQ.COM
Show More News
